Latest Regulatory News


Regulatory Flexibility for Veterinary Medicines during COVID-19 Pandemic

The European Commission, EMA and the Coordination Group for Mutual Recognition and Decentralised Procedure (Veterinary) have issued guidance on adaptations to the regulatory framework to companies that develop, manufacture and distribute veterinary medicines in order to address some of the constraints posed by the COVID-19 pandemic.

According to the jointly developed question-and-answer (Q&A) document, regulatory rules for veterinary medicines should be applied with greater flexibility in the context of COVID-19 when necessary to mitigate the risk of supply disruptions caused by the pandemic. The guidance aims to ensure that high-quality, safe and effective veterinary medicines that are essential for protecting public and animal health continue to be available during the public health crisis.

The Q&A document sets out areas where regulatory flexibility is possible to address some of the constraints marketing authorisation holders in the veterinary sector may be faced with in the context of the pandemic. These measures cover different areas of regulation, including:

  • marketing authorisation procedures;
  • safety monitoring; and
  • inspections of manufacturing facilities and good manufacturing practice (GMP) for veterinary medicines.

The Q&A document was also endorsed by the EU Executive Steering Group on Shortages of Medicines Caused by Major Events, which provides strategic leadership for urgent and coordinated action on possible shortages within the EU during this pandemic.

The Q&A document will be continuously updated. Veterinary stakeholders are advised to visit this page for regulatory information on the impact of the COVID-19 pandemic on veterinary medicines.

 

Latest Regulatory News

Oct-2021

News > Vet Medicine

Use of Antibiotics in Animals is Decreasing

A report published in June 2021 by the EFSA, the European Medicines Agency (EMA) and the European Centre for Disease Prevention and Control (ECDC) states...

Read More

Sep-2021

Biocides > News

A New Era in Pest Control

Image: Bayer Environmental Science This September will see the launch of a professional-use cholecalciferol rodenticide to the European market, which can be used in open...

Read More

Contact

LKC Switzerland Ltd
Hauptstrasse 10
P.O. Box 167
4414 Füllinsdorf
Switzerland

Phone: +41 (0) 61 906 8500
LKC@lkc-ltd.com

Information

Registration Number: CHE-113.597.134

Upcoming Events

2007-2021 © Copyright LKC Switzerland Ltd

Sign Up for Newsletter

x